These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 16360362)

  • 1. Natural history of valvular regurgitation using side-by-side echocardiographic analysis in anorexigen-treated subjects.
    Klein AL; Griffin BP; Grimm RA; Rodriguez LL; Sallach JA; Morehead AJ
    Am J Cardiol; 2005 Dec; 96(12):1711-7. PubMed ID: 16360362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic prevalence of mitral and/or aortic regurgitation in patients exposed to either fenfluramine-phentermine combination or to dexfenfluramine.
    Kancherla MK; Salti HI; Mulderink TA; Parker M; Bonow RO; Mehlman DJ
    Am J Cardiol; 1999 Dec; 84(11):1335-8. PubMed ID: 10614800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group.
    Weissman NJ; Tighe JF; Gottdiener JS; Gwynne JT
    N Engl J Med; 1998 Sep; 339(11):725-32. PubMed ID: 9731088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic valvular regurgitation: prevalence and clinical characteristics in a predominantly obese adult population not taking anorexigens.
    Gardin JM; Constantine G; Davis K; Leung C; Reid CL
    Echocardiography; 2006 Aug; 23(7):569-76. PubMed ID: 16911330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine.
    Ryan DH; Bray GA; Helmcke F; Sander G; Volaufova J; Greenway F; Subramaniam P; Glancy DL
    Obes Res; 1999 Jul; 7(4):313-22. PubMed ID: 10440587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of valvular regurgitation 1 year after discontinuation of dexfenfluramine therapy. A randomized, double-blind, placebo-controlled trial.
    Weissman NJ; Panza JA; Tighe JF; Gwynne JT
    Ann Intern Med; 2001 Feb; 134(4):267-73. PubMed ID: 11182836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The progression of fenfluramine-associated valvular heart disease assessed by echocardiography.
    Mast ST; Jollis JG; Ryan T; Anstrom KJ; Crary JL
    Ann Intern Med; 2001 Feb; 134(4):261-6. PubMed ID: 11182835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of Doppler echocardiography for the assessment of changes in valvular regurgitation: comparison of side-by-side versus serial interpretation.
    Weissman NJ; Panza JA; Tighe JF; Perras ST; Kushner H; Gottdiener JS
    J Am Coll Cardiol; 2001 May; 37(6):1614-21. PubMed ID: 11345374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of valvular-regurgitation associated with dexfenfluramine three to five months after discontinuation of treatment.
    Weissman NJ; Tighe JF; Gottdiener JS; Gwynne JT
    J Am Coll Cardiol; 1999 Dec; 34(7):2088-95. PubMed ID: 10588229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic usefulness and prognostic implications of the mitral E/E' ratio in patients with heart failure and severe secondary mitral regurgitation.
    Bruch C; Klem I; Breithardt G; Wichter T; Gradaus R
    Am J Cardiol; 2007 Sep; 100(5):860-5. PubMed ID: 17719334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of color flow mapping and Doppler echocardiography in the quantification of mitral regurgitation in patients with mitral valve prolapse or rheumatic heart disease.
    Pinheiro AC; Mancuso FJ; Hemerly DF; Kiyose AT; Campos O; de Andrade JL; de Paola AA; de Camargo Carvalho AC; Moises VA
    J Am Soc Echocardiogr; 2007 Oct; 20(10):1141-8. PubMed ID: 17588714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of coexistent mitral regurgitation after aortic valve replacement.
    Schubert SA; Yarboro LT; Madala S; Ayunipudi K; Kron IL; Kern JA; Ailawadi G; Stukenborg GJ; Ghanta RK
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):1032-9, 1042.e1. PubMed ID: 26876419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Color M-mode regurgitant flow propagation velocity: a new echocardiographic method for grading of mitral regurgitation.
    Akdemir R; Ozhan H; Bulur S; Unlu H; Gunduz H; Arinc H; Yildiz A; Uyan C
    Echocardiography; 2005 Oct; 22(9):713-22. PubMed ID: 16194164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calculation of the regurgitation fraction in mitral insufficiency by Doppler echocardiography using a study of the zone of flow convergence].
    Gallet B; Tribouilloy C; Abassade P; Adams C; Mazouz S; Lefèvre T; Barthélemy M; Saudemont JP; Hiltgen M
    Arch Mal Coeur Vaiss; 1997 Jan; 90(1):17-25. PubMed ID: 9137711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to measure severity of mitral regurgitation: valvular heart disease.
    Grayburn PA
    Heart; 2008 Mar; 94(3):376-83. PubMed ID: 18276823
    [No Abstract]   [Full Text] [Related]  

  • 16. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.
    Jick H; Vasilakis C; Weinrauch LA; Meier CR; Jick SS; Derby LE
    N Engl J Med; 1998 Sep; 339(11):719-24. PubMed ID: 9731087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the test: the reliability of echocardiography in the sequential assessment of valvular regurgitation.
    Gottdiener JS; Panza JA; St John Sutton M; Bannon P; Kushner H; Weissman NJ
    Am Heart J; 2002 Jul; 144(1):115-21. PubMed ID: 12094197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine.
    Hensrud DD; Connolly HM; Grogan M; Miller FA; Bailey KR; Jensen MD
    Mayo Clin Proc; 1999 Dec; 74(12):1191-7. PubMed ID: 10593346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultrasound stethoscope in the rapid assessment of left ventricular systolic function and valvular regurgitation--personal experience].
    Szymański P; Lipczyńska M; Klisiewicz A; Kraszewski K; Konka M; Tyczyński P; Hoffman P
    Przegl Lek; 2004; 61(6):572-5. PubMed ID: 15724637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doppler echocardiographic assessment of long-term progression of mitral stenosis in 103 patients: valve area and right heart disease.
    Sagie A; Freitas N; Padial LR; Leavitt M; Morris E; Weyman AE; Levine RA
    J Am Coll Cardiol; 1996 Aug; 28(2):472-9. PubMed ID: 8800128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.